The earnings transcript for UnitedHealth Group Incorporated for the second quarter of 2019 indicates several positive factors that are likely to influence the stock price in the short term:

- **Strong Financial Performance**: The company reported strong revenue and earnings growth, with total revenues growing 8% year-over-year to $60.6 billion and adjusted earnings per share advancing 15% to $3.60[1][3][4].
- **Increased Guidance**: UnitedHealth Group raised its full-year adjusted earnings per share guidance to $14.70-$14.90, reflecting confidence in continued performance[1][3][4].
- **Operational Efficiencies**: The company highlighted various initiatives to lower costs, improve the consumer experience, and advance value-based care, which are expected to contribute to long-term sustainable growth[1][3][4].
- **Expansions and Partnerships**: Notable expansions, such as the combination with DaVita Medical Group and the strategic relationship with John Muir Health, demonstrate the company's ability to grow through strategic partnerships and acquisitions[1][3][4].

Given these positive indicators, the stock is likely to experience a positive impact in the short term.

**Rating: 1**